Acurx Pharmaceuticals
ACXP
ACXP
12 hedge funds and large institutions have $1.86M invested in Acurx Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
4
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$310K |
| 2 |
2
Osaic Holdings
Scottsdale,
Arizona
|
$55.4K |
| 3 |
3
BlackRock
New York
|
$55.9K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$10K |
| 5 |
5
Wells Fargo
San Francisco,
California
|
$215 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $969K | 280,000 | -600,000 | -68% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $310K | 89,485 | +89,485 | New |
|
3
Geode Capital Management
Boston,
Massachusetts
| $267K | 77,283 | – | – |
|
4
Millennium Management
New York
| $76K | 22,051 | -7,045 | -24% |
|
|
TWC
5
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $63.4K | 18,656 | – | – |
|
|
6
BlackRock
New York
| $55.9K | 16,161 | +522 | +3% |
|
|
7
Osaic Holdings
Scottsdale,
Arizona
| $55.4K | 16,000 | +4,000 | +33% |
|
|
TAM
8
Tocqueville Asset Management
New York
| $34.9K | 10,100 | – | – |
|
|
BAM
9
Belpointe Asset Management
Reno,
Nevada
| $10.4K | 3,000 | – | – |
|
|
10
UBS Group
Zurich,
Switzerland
| $10K | 2,904 | +168 | +6% |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $10K | 2,890 | -5 | -0.2% |
|
|
12
Wells Fargo
San Francisco,
California
| $215 | 62 | +1 | +2% |
|
|
DAM
13
Draper Asset Management
Smithtown,
New York
| – | – | -266,025 | Closed |
|
14
Bank of America
Charlotte,
North Carolina
| – | – | -10 | Closed |
|
|
CFGS
15
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|